Zimmer Biomet Holdings (ZBH) Short-Term Debt repayments (2018 - 2023)
Zimmer Biomet Holdings' quarterly Short-Term Debt repayments came in at $305.0 million in Q4 2023, up 175.31% quarter-over-quarter from -$405.0 million in Q3 2023.
Zimmer Biomet Holdings has reported Short-Term Debt repayments for 2 years, with the latest figure at $305.0 million in Q4 2023.
- For the quarter ending Q4 2023, Short-Term Debt repayments changed N/A year-over-year to $305.0 million; the trailing twelve-month figure through Dec 2024 stood at $165.0 million (down 49.23% YoY), and the FY2024 full-year result was $50.0 million, down 84.62% from the prior year.
- Short-Term Debt repayments for Q4 2023 stood at $305.0 million, up from -$405.0 million in the prior quarter.
- The five-year high for Short-Term Debt repayments was $305.0 million in Q4 2023, with the low at -$405.0 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 259.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 305.00 Mn |
| Dec 31, 2023 | 305.00 Mn |
| Sep 30, 2023 | -405.00 Mn |
| Sep 30, 2023 | -405.00 Mn |
| Jun 30, 2023 | 265.00 Mn |
| Jun 30, 2023 | 265.00 Mn |
| Mar 31, 2023 | 160.00 Mn |
| Mar 31, 2023 | 160.00 Mn |
| Sep 30, 2018 | 25.00 Mn |
| Sep 30, 2018 | 25.00 Mn |